27 jun: Carlsberg/RBC: Indleder dækning med "sector perform"
28 jun: USA/aktier: Opløstende nøgletal løftede markedet
27-06-2012 23:56:00

WSJ BLOG/Health: Pharmacies Try Offering Free HIV Testing

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Timothy W. Martin

Pharmacists and other drugstore staff already conduct tests for high-blood pressure, cholesterol levels and diabetes at in-store clinics.

Now, in a pilot program with federal health officials announced Tuesday, Walgreen Co. and other pharmacies will examine whether they can become a go-to stop for those seeking HIV testing.

So far, seven stores -- including three operated by Walgreen in Chicago, Washington D.C. and Lithonia, Ga. -- are offering the HIV tests for free. Spotting a patient early on with HIV decreases the likelihood the disease will be transmitted to other people and helps get an infected individual on drug treatment and therapy earlier.

By the end of the summer, the Centers for Disease Control and Prevention plans to add 17 more pharmacies to the pilot program, dividing the participating drug stores equally between urban and rural locations.

The CDC estimates 1.1 million people in the U.S. live with HIV, but nearly one in five of those infected is unaware of their condition. Health officials six years ago recommended that all adolescents and adults between the ages of 13 to 64 get tested at least once for HIV.

Testing numbers have risen in recent years. About 45% of Americans aged 18 to 64 in 2009 had reported getting tested for HIV at some point in their lives, according to CDC research, up from the 40% observed in 2006.

The two-year pilot is a test run for how drug stores and community pharmacies across the country could one day offer HIV testing. CDC officials will study the amount of time, resources and cost required.

"We want to get a sense of how cumbersome this process would be and the approximate cost of the service for the pharmacies," Kevin Fenton, a CDC director for the center focusing on HIV/AIDS, tells the Health Blog.

The findings will help health officials establish a model that other pharmacies could follow, says Paul Weidle, the CDC epidemiologist in charge of the project.

Free HIV tests are widely available at local health departments and community organizations. Most people get tested at their doctor's office as part of routine health screens, paying a nominal fee for the test or the visit. Test samples are collected by oral swab or from a blood sample taken by a finger prick device.

Pharmacists or nurse practitioners at the pilot clinics use an oral swab of the gums or inside the cheek. The FDA-approved HIV tests produce results within 20 minutes. If the test comes out as a preliminary positive, the patient will be referred to a local health-care provider for confirmation and care.

The tests are conducted in private rooms. "This is a non-descript type of place. Nobody really knows what you're in there for," said Mike Ellis, Walgreen's vice president of specialty and infusion.

Walgreen has also trained its pharmacists in recent years to take tests for blood pressure, cholesterol and diabetes. The pharmacists who can provide counseling about HIV treatments or conduct a test receive about 25 hours of training every year, said Glen Pietrandoni, senior manager of HIV/AIDS and Hepatitis at Walgreen.

-For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

(END) Dow Jones Newswires

June 27, 2012 17:56 ET (21:56 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
25 aug
GEN
Stop nu det mobberi GW   Jeg elsker at følge den aktie, og det er så trist at du altid skal hævde di..
23
24 aug
FING-B
Sig mig.. har du slet ingen skam i livet !!.. du stjæler ENDNU ENGANG et skriv fra en anden skribent..
22
26 aug
FING-B
Når Nordea alene i deres analyse tager udgangspunkt i konkurrencesituationen flere år fremme i tiden..
18
23 aug
BAVA
Bavarian Nordic har sammen med Crucell og div. myndigheder igangsat to interessante nye forsøg med M..
18
24 aug
ZEAL
I Solothum uden for Bern i Svejts ligger en fabrik, hvor der er blevet investeret 50 mio CHF det sen..
17
23 aug
 
http://borsen.dk/nyheder/politik/artikel/1/330221/opgoerelse_viser_nye_milliarder_tabt_til_skattesvi..
15
23 aug
DANSKE
Tro ikke på 6212 han er blot en bondeknold, der efterhånden er gået kold arme stakkels lille trold, ..
14
25 aug
ZEAL
Her kommer endnu et bud på, hvor Zealand skal hen efter en FDA godkendelse af iGlarlixi. Jeg siger k..
13
25 aug
GEN
Sådan ser jeg det bestemt heller ikke !! GW har hele tiden, på hans helt egen facon, stået ved at ha..
12
25 aug
GEN
Backtraderen har lavet endnu et berømmeligt raid. Og så - nå ja - GAB!
12

Rockwool/Jyske: Ledelsen gør klar til at fokusere på vækst igen

26-08-2016 15:15:02
Det spareprogram, som Rockwools topchef, Jens Birgersson, igangsatte sidste år, begynder så småt at nærme sig en afslutning. Og dermed kan stenuldsproducentens ..

Simcorp/CEO: Abonnementsmodel bag rekordstor ordrebog

26-08-2016 13:14:42
Softwareselskabet Simcorp kunne ved udgangen af første halvår notere sig den fedeste ordrebog i selskabets historie.Det er der en god forklaring på, lyder det f..

Aktier/middag: Genmab og Novo trækker ned inden nyt fra Yellen

26-08-2016 11:41:55
Kursfald i blandt andre Novo Nordisk og Genmab medvirker til at sætte det danske aktiemarked en smule under pres fredag middag.Markedet holder vejret op til eft..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas: Tysk konkurrent bekræfter dialog om 183 MW til Chile

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2016  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
29. august 2016 07:22:00
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20160826.1 - EUROWEB3 - 2016-08-29 07:22:00 - 2016-08-29 07:22:00 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x